Adamanthyl Carbonyl Proline is a proline-based nootropic drug.
It is structurally similar to the well-known nootropic drug piracetam, and is sometimes referred to as "Prolcem" or "Prolcemid".
Adamanthyl Carbonyl Proline has been shown to improve cognitive function in animal studies, and has been proposed as a potential treatment for Alzheimer's disease and other forms of dementia.
However, no clinical trials have been conducted to confirm these effects in humans.
Adamanthyl Carbonyl Proline is not currently available as a dietary supplement or prescription medication in the United States.
|Adamantyl Carbonyl Proline For Sale|
|Molar Mass||277.36 g/mol|
|IUPAC Name||1-(adamantane-1-carbonyl)pyrrolidine-2-carboxylic acid|